Мария Кондратова - Кривое зеркало жизни. Главные мифы о раке, и что современная наука думает о них

Cytotoxic Chemotherapy Mechanisms of Action. https://www.mycancergenome.org/content/molecular-medicine/pathways/cytotoxic-chemotherapy-mechanisms-of-action.

DeVita V. T. Jr, Chu E. A history of cancer chemotherapy. Cancer Research , 2008, 68 (21), 8643–8653.

Jordan V. C. Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer // Endocrine-Related Cancer , 2014, 21 (3), 235–246.

Nowell P. C. The clonal evolution of tumor cell populations // Science , 1976, 194 (4260), 23–28.

Vogelstein B., Kinzler K. W. Cancer genes and the pathways they control // Nature Medicine , 2004, 10 (8), 789–799.

Vu T., Claret F. X. Trastuzumab: updated mechanisms of action and resistance in breast cancer // Frontiers in Oncology , 2012, 2, 62.

White J. Secret superheroes // New Scientist , 223 (2979), 28–29.

Склут Р. Бессмертная жизнь Генриетты Лакс. — М.: Карьера Пресс, 2012.

Abegglen L. M., Caulin A. F., Chan A., Lee K., Robinson R., Campbell M. S., Kiso W. K., Schmitt D. L., Waddell P. J., Bhaskara S., Jensen S. T., Maley C. C., Schiffman J. D. Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans // The Journal of the American Medical Association , 2015, 314 (17), 1850–1860.

Dawson M. A., Kouzarides T. Cancer epigenetics: from mechanism to therapy // Cell , 2012, 150 (1), 12–27.

Flynn R. L., Cox K. E., Jeitany M., Wakimoto H., Bryll A. R., Ganem N. J., Bersani F., Pineda J. R., Suvà M. L., Benes C. H., Haber D. A., Boussin F. D., Zou L. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors // Science , 2015, 347 (6219), 273–277.

Hao X., Luo H., Krawczyk M., Wei W., Wang W., Wang J., Flagg K., Hou J., Zhang H., Yi S., Jafari M., Lin D., Chung C., Caughey B. A., Li G., Dhar D., Shi W., Zheng L., Hou R., Zhu J., Zhao L., Fu X., Zhang E., Zhang C., Zhu J. K., Karin M., Xu R. H., Zhang K. DNA methylation markers for diagnosis and prognosis of common cancers // Proceedings of the National Academy of Sciences , 2017, 114 (28), 7414–7419.

Heyn H., Esteller M. DNA methylation profiling in the clinic: applications and challenges // Nature Reviews Genetics , 2012, 13 (10), 679–692.

Jones P. A., Issa J. P., Baylin S. Targeting the cancer epigenome for therapy // Nature Reviews Genetics , 2016, 17 (10), 630–641.

Levine A. J., Oren M. The first 30 years of p53: growing ever more complex // Nature Reviews Cancer , 2009, 9 (10), 749–758.

Lin J., Epel E., Blackburn E. Telomeres and lifestyle factors: roles in cellular aging // Mutation Research , 2012, 730 (1–2), 85–89.

Ouyang L., Shi Z., Zhao S., Wang F. T., Zhou T. T., Liu B., Bao J. K. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis // Cell Proliferation , 2012, 45 (6), 487–498.

Nebbioso A., Tambaro F. P., Dell’Aversana C., Altucci L. Cancer epigenetics: Moving forward // PLoS Genetics , 2018, 14 (6), e1007362.

Reya T., Morrison S. J., Clarke M. F., Weissman I. L. Stem cells, cancer, and cancer stem cells // Nature , 2001, 414 (6859), 105–111.

Shay J. W., Wright W. E. Role of telomeres and telomerase in cancer // Seminars in Cancer Biology , 2011, 21 (6), 349–353.

Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors // Cell , 2006, 126 (4), 663–676.

Alexander J. L., Wilson I. D., Teare J., Marchesi J. R., Nicholson J. K., Kinross J. M. Gut microbiota modulation of chemotherapy efficacy and toxicity // Nature Reviews Gastroenterology & Hepatology , 2017, 14 (6), 356–365.

Ambalam P., Raman M., Purama R. K., Doble M. Probiotics, prebiotics and colorectal cancer prevention // Best Practice & Research Clinical Gastroenterology , 2016, 30 (1), 119–131.

Diet and cancer. https://www.cancerresearchuk.org/about-cancer/causes-of-cancer/diet-and-cancer

Gopalakrishnan V., Spencer C. N., Nezi L., Reuben A., Andrews M. C., Karpinets T. V., Prieto P. A., Vicente D., Hoffman K., Wei S. C., Cogdill A. P., Zhao L., Hudgens C. W., Hutchinson D. S., Manzo T., Petaccia de Macedo M., Cotechini T., Kumar T., Chen W. S., Reddy S. M. & others. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients // Science , 2018, 359 (6371), 97–103.

Greenwald P., Clifford C. K., Milner J. A., Eur J. Diet and cancer prevention // Cancer , 2001, 37 (8), 948–965.

Kelly C. R., Kahn S., Kashyap P., Laine L., Rubin D., Atreja A., Moore T., Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook // Gastroenterology , 2015, 149 (1), 223–237.

Martinez-Outschoorn U. E., Peiris-PagЕs M., Pestell R. G., Sotgia F., Lisanti M. P. Cancer metabolism: a therapeutic perspective // Nature Reviews Clinical Oncology , 2017, 14 (1), 11–31.

Ostrander G. K., Cheng K. C., Wolf J. C., Wolfe M. J. Shark cartilage, cancer and the growing threat of pseudoscience // Cancer Research , 2004, 64 (23), 8485–8491.

Perez P. F., DorЕ J., Leclerc M., Levenez F., Benyacoub J., Serrant P., Segura-Roggero I., Schiffrin E. J., Donnet-Hughes A. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? // Pediatrics , 2007, 119 (3), 724–732.

Schwabe R. F., Jobin C. The microbiome and cancer // Nature Reviews Cancer , 2013, 13 (11), 800–812.

Van Der Weyden M. B., Armstrong R. M., Gregory A. T. The 2005 Nobel Prize in physiology or medicine // The Medical Journal of Australia , 2005, 183 (11–12), 612–614.

Vander Heiden M. G., Cantley L. C., Thompson C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation // Science , 2009, 324 (5930), 1029–1033.

Umar A., Dunn B. K., Greenwald P. Future directions in cancer prevention // Nature Reviews Cancer , 2012, 12 (12), 835–848.

Циммер К. Паразит — царь природы. Тайный мир самых опасных существ на Земле. — М.: Альпина нон-фикшн, 2012.

Bosman F. T., Stamenkovic I. Functional structure and composition of the extracellular matrix // The Journal of Pathology , 2003, 200 (4), 423–428.

Bussard K. M., Mutkus L., Stumpf K., Gomez-Manzano C., Marini F. C. Tumor-associated stromal cells as key contributors to the tumor microenvironment // Breast Cancer Research , 2016, 18 (1), p. 84.

Chaffer C. L., Weinberg R. A. A perspective on cancer cell metastasis // Science , 2011, 331 (6024), 1559–1564.

Cuzick J., Otto F., Baron J. A., Brown P. H. & others. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement // The Lancet Oncology , 2009, 10 (5), 501–507.

Dvorak H. F. Tumors: Wounds That Do Not Heal. Similarities Between Tumor Stroma Generation and Wound Healing // The New England Journal of Medicine , 1986, 315 (26), 1650–1659.

Folkman J. Role of angiogenesis in tumor growth and metastasis // Seminars in Oncology , 2002, (6 Suppl 16), 15–8.

Franzetti G. A., Laud-Duval K., van der Ent W., Brisac A., Irondelle M., Aubert S., Dirksen U., Bouvier C., de Pinieux G., Snaar-Jagalska E., Chavrier P., Delattre O. Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells // Oncogene , 2017, 36 (25), 3505–3514.

Frantz C., Stewart K. M., Weaver V. M. The extracellular matrix at a glance // Journal of Cell Science , 2010, 123 (Pt 24), 4195–4200.

Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J. F., Harrington K., Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells // Nature Cell Biology , 2007, 9 (12), 1392–1400.

Kalluri R. The biology and function of fibroblasts in cancer // Nature Reviews Cancer , 2016, 16 (9), 582–598.

Kaplan R. N., Riba R. D., Zacharoulis S., Bramley A. H. & others. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche // Nature , 2005, 438 (7069), 820–827.

Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment // Cell , 2010, 141 (1), 52–67.

Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation // Nature , 2008, 454 (7203), 436–444.

Nelson C. M., Bissell M. J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer // Annual Review of Cell and Developmental Biology, 2006, 22, 287–309.

Pachmayr E., Treese C., Stein U. Underlying Mechanisms for Distant Metastasis — Molecular Biology // Visceral Medicine , 2017, 33 (1), 11–20.

Peinado H., Lavotshkin S., Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts // Seminars in Cancer Biology , 2011, 21 (2), 139–146.

Rich R. M., Rosenfeld P. J., Puliafito C. A., Dubovy S. R. & others. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration // Retina , 2006, 26 (5), 495–511.

Yang J., Weinberg R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis // Developmental Cell , 2008, 14 (6), 818–829.

Терапевтические антитела. Спецпроект электронного журнала «Биомолекула». https://biomolecula.ru/specials/antitela.

Ярилин А. А. Иммунология. — М.: ГЭОТАР-Медиа, 2010.

Blum J. S., Wearsch P. A., Cresswell P. Pathways of antigen processing // Annual Review of Immunology , 2013, 31, 443–473.

Bottazzi B., Riboli E., Mantovani A. Aging, inflammation and cancer // Seminars in Immunology , 2018, 40, 74–82.

June C. H., O’Connor R. S., Kawalekar O. U., Ghassemi S., Milone M. C. CAR T cell immunotherapy for human cancer // Science , 2018, 359 (6382), 1361–1365.

Kucerova P., Cervinkova M. Spontaneous regression of tumour and the role of microbial infection — possibilities for cancer treatment // Anticancer Drugs , 2016, 27 (4), 269–277.

Liu J. K. The history of monoclonal antibody development — Progress, remaining challenges and future innovations // Annals of Medicine and Surgery (Lond), 2014, 3 (4), 113–116.